Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5676) to amend title XVIII of the Social Security Act to authorize the suspension of payments by Medicare prescription drug plans and…
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5676) to amend title XVIII of the Social Security Act to authorize the suspension of payments by Medicare prescription drug plans and MA-PD plans pending investigations of credible allegations of fraud by pharmacies, as amended.
Mr. Speaker, I ask unanimous consent that all Members have 5 legislative days to revise and extend their remarks and include extraneous material on H.R. 5676, currently under consideration.
Mr. Speaker, I yield myself such time as I may consume.
Mr. Speaker, I stand today in strong support of H.R. 5676, a bipartisan bill centered on protecting Medicare beneficiaries from abusive opioid prescribing, while ensuring appropriate access to medically necessary medications. This bill strikes a balance, which we need.
H.R. 5676, introduced by our colleagues--Mr. MacArthur, Mr. Blumenauer, Mr. Schweikert, Mr. Collins, Ms. Kuster, and Mr. Tonko-- extends an existing authority in the Medicare fee-for-service program to Medicare Advantage and prescription drug plans.
According to a recent report released by the Department of Health and Human Services' Office of Inspector General, one-third of Medicare part D beneficiaries received an opioid prescription in 2016, costing the program $4.1 billion and representing as many as 79.4 million prescriptions. The report found that as many as half a million part D beneficiaries received high amounts of opioids, with almost 70,000 receiving extreme amounts of opioids, many of them as a result of doctor shopping.
For years, the Medicare fee-for-service program has been able to suspend payments to a provider or a supplier pending an investigation of a credible allegation of fraud against the provider or supplier. Extending this authority to the Medicare Advantage and prescription drug plans will help bridge the gap in the care of beneficiaries and halt the fraudulent activity that contributes to the opioid crisis.
I would like to thank my colleagues on both sides of the aisle on the Ways and Means Committee for their commitment to working cooperatively on this, and also our colleagues on the Energy and Commerce Committee, particularly Congressman Burgess, who chairs the Health Subcommittee, and also Chairman Walden. They played a role in laying the groundwork for policies like this that crack down on abusers.
Mr. Speaker, I look forward to continuing to work on this issue on both sides of the aisle and with the administration on policies that will further strengthen the integrity of the Medicare program.
Mr. Speaker, I reserve the balance of my time.
House of Representatives,
Committee on Ways and Means,
Washington, DC, June 8, 2018.
Hon. Greg Walden,
Chairman, Committee on Energy and Commerce,
Washington, DC.
Dear Chairman Walden: I write to you regarding several
opioid bills the Committee on Ways and Means ordered
favorably reported to address the opioid epidemic. The
following bills were also referred to the Committee on Energy
and Commerce.
I ask that the Committee on Energy and Commerce waive
formal consideration of the following bills so that they may
proceed expeditiously to the House Floor:
H.R. 5774, Combatting Opioid Abuse for Care in Hospitals
(COACH) Act;
H.R. 5775, Providing Reliable Options for Patients and
Educations Resources (PROPER) Act;
H.R. 5776, Medicare and Opioid Safe Treatment (MOST) Act;
H.R. 5773, Preventing Addition for Susceptible Seniors
(PASS) Act;
H.R. 5676, Stop Excessive Narcotics in our Retirement
(SENIOR) Communities Protection Act; and
H.R. 5723, Expanding Oversight of Opioid Prescribing and
Payment Act.
I acknowledge that by waiving formal consideration of the
bills, the Committee on Energy and Commerce is in no way
waiving its jurisdiction over the subject matter contained in
those provisions of the bills that fall within your Rule X
jurisdiction. I would support your effort to seek appointment
of an appropriate number of conferees on any House-Senate
conference involving this legislation.
I will include a copy of our letters in the Congressional
Record during consideration of this legislation on the House
floor.
Sincerely,
Kevin Brady,
Chairman.
Mr. Speaker, I yield myself such time as I may consume.
Mr. Speaker, I just want to go into a little bit more detail and focus on how it is that we are here today and why there is an urgency to this.
The gentlewoman just mentioned some staggering statistics: 9,000 pills per individual over a decade in a particular town. It tells you that the system has gotten entirely out of balance.
There are a lot of explanations and there are not a lot of clean hands:
We know that there have been government policies that have driven, in part, the opioid crisis by evaluating providers on whether or not pain satisfaction has been completed on the patient side of things;
We know that in some cases there have been healthcare providers that have not gone into the detail of getting to the root of a problem;
We know that we, as a culture, put extraordinary pressure on healthcare providers when we tell them we want them to help us get out of pain; and when we do that, sometimes, Mr. Speaker, unfortunately, we put ourselves at risk, and we know that pharma has a lot to answer for.
All of those things we know are true, and I think what is encouraging to me is this idea of people coming together on both sides and recognizing we don't have to live this way anymore. We don't have to have a system that drives people in this direction.
Let me just go back to this inspector general report from the Department of Health and Human Services that says that 79 million prescriptions involving opioids were prescribed in 2016 alone. That is a staggering number.
And I think that, if we are diligent, if we are forward thinking, and if we continue to work together, both sides of the aisle coming together, Mr. Speaker, I think that, in 10 years, our country will be having a different conversation on opioids. It may take that long, but I think, in 10 years' time, if we do the work, if we are committed to this, we can look back and we can say: That was a time when the United States came together around a public health crisis; that was a time when people had a general understanding that they needed to get over the normal approaches on things; and that was a time that people came together with holistic approaches.
Mr. Speaker, I reserve the balance of my time.
Mr. Speaker, I yield 3 minutes to the gentleman from New Jersey (Mr. MacArthur)
Mr. Speaker, I yield an additional 1 minute to the gentleman from New Jersey.
Mr. Speaker, I yield myself the balance of my time.
Mr. Speaker, in closing, in a nutshell, I think the gentlewoman from California put it well. What she was arguing was this bill strikes a balance,
which it does. It is designed to focus our time, our attention, and our energies on making sure that the bad actors are weeded out, that the abuse is stopped, and that we can bring balance to the system.
The Stop Excessive Narcotics in Our Retirement Communities Protection Act, or SENIOR Communities Protection Act, is another step in this direction to protect our Nation's seniors. This bill was brought to the floor through a bipartisan committee process, and I urge its passage.
Mr. Speaker, I yield back the balance of my time.
Mr. Speaker, on that I demand the yeas and nays.